Why Ozempic users are actually spending more on high-end chocolate

Chocolate sales are rising faster among people using weight-loss drugs than in the rest of the population, according to a new report.

Swiss chocolatier Lindt & Sprüngli cited data countering predictions that GLP-1 drugs would reduce interest in sweets.

Semaglutide medications, like Ozempic and Wegovy, mimic the natural hormone GLP‑1 (glucagon‑like peptide‑1), while tirzepatides (such as Mounjaro and Zepbound) target both GLP-1 receptors and GIP (glucose-dependent insulinotropic polypeptide) receptors.